you are viewing a single comment's thread.
They are going to burn the cash in no time. No revenues to speak of and now they need to market the test.
you better cover early mon shorty before this goes to 7
I'm not short. You just need to be realistic in your expectations. This company has had 3 secondaries since going public and all of them at lower prices. $3 million just doesn't go very far when you want to roll out an expensive test for a relatively small population.